Homepage
AI Research
Research
Overview
Causality
Representation Learning
Survival Analysis
Our Tests
Ataraxis Breast
Overview
Recurrence Risk (RISK)
Chemotherapy benefit (CTX)
Neoadjuvant response (NEO)
Ataraxis Breast
About Us
News
Evidence
Careers
Contact Us
Copyright © 2025, ataraxis.ai, All Rights Reserved.
Homepage
AI Research
Research
Overview
Causality
Representation Learning
Survival Analysis
Ataraxis Breast
Our Tests
Ataraxis Breast
Overview
Recurrence risk (RISK)
Chemotherapy benefit (CTX)
Neoadjuvant response (NEO)
Ataraxis Breast
About Us
News
Evidence
Careers
Ordering Portal
Contact Us
Ordering Portal
Contact Us
Ordering Portal
Ataraxis lands $20.4 million Series A to accelerate clinical deployment of AI precision medicine
Read More
January 5, 2026
Press Release
Ataraxis AI and Unicancer Partner to Validate Ataraxis™ Breast Prognostic tool using Global Phase III Trial Data